Top

Published in:

Open Access 01-12-2012 | Study protocol

Pregnancy and liver adenoma management: PALM-study

Authors: Susanna M van Aalten, Mirelle E E Bröker, J J V Busschbach, Harry J de Koning, Robert A de Man, Eric A P Steegers, Ewout W Steyerberg, Turkan Terkivatan, Jan N M IJzermans

Published in: BMC Gastroenterology | Issue 1/2012

Abstract

Background

Hepatocellular adenoma (HCA) in pregnant women requires special considerations because of the risk of hormone induced growth and spontaneous rupture, which may threaten the life of both mother and child. Due to scarcity of cases there is no evidence-based algorithm for the evaluation and management of HCA during pregnancy. Most experts advocate that women with HCA should not get pregnant or advise surgical resection before pregnancy. Whether it is justified to deny a young woman a pregnancy, as the biological behavior may be less threatening than presumed depends on the incidence of HCA growth and the subsequent clinical events during pregnancy.

We aim to investigate the management and outcome of HCA during pregnancy and labor based on a prospectively acquired online database in the Netherlands.

Methods/design

The Pregnancy And Liver adenoma Management (PALM) - study is a multicentre prospective study in three cohorts of pregnant patients. In total 50 pregnant patients, ≥ 18 years of age with a radiologically and/or histologically proven diagnosis of HCA will be included in the study. Radiological diagnosis of HCA will be based on contrast enhanced MRI. Lesions at inclusion must not exceed 5 cm. The study group will be compared to a healthy control group of 63 pregnant patients and a group of 63 pregnant patients with diabetes mellitus without HCA. During their pregnancy HCA patients will be closely monitored by means of repetitive ultrasound (US) at 14, 20, 26, 32 and 38 weeks of gestation and 6 and 12 weeks postpartum. Both control groups will undergo US of the liver at 14 weeks of gestation to exclude HCA lesions in the liver. All groups will be asked to fill out quality of life related questionnaires.

Discussion

The study will obtain information about the behaviour of HCA during pregnancy, the clinical consequences for mother and child and the impact of having a HCA during pregnancy on the health related quality of life of these young women. As a result of this study we will propose a decision-making model for the management of HCA during pregnancy.

Trial registration

Dutch trial register: NTR3034

Reddy KR, Schiff ER: Approach to a liver mass. Semin Liver Dis. 1993, 13 (4): 423-435.CrossRefPubMed

Rooks JB, Ory HW, Ishak KG, Strauss LT, Greenspan JR, Hill AP, Tyler CW: Epidemiology of hepatocellular adenoma. The role of oral contraceptive use. JAMA. 1979, 242 (7): 644-648. 10.1001/jama.1979.03300070040020.CrossRefPubMed

Baum JK, Bookstein JJ, Holtz F, Klein EW: Possible association between benign hepatomas and oral contraceptives. Lancet. 1973, 2 (7835): 926-929.CrossRefPubMed

Baek S, Sloane CE, Futterman SC: Benign liver cell adenoma associated with use of oral contraceptive agents. Ann Surg. 1976, 183 (3): 239-242. 10.1097/00000658-197603000-00003.CrossRefPubMedPubMedCentral

Horvath E, Kovacs K, Ross RC: Letter: Benign hepatoma in a young woman on contraceptive steroids. Lancet. 1974, 1 (7853): 357-358.CrossRefPubMed

Lingeman CH: Letter: Liver-cell neoplasms and oral contraceptives. Lancet. 1974, 1 (7846): 64-CrossRefPubMed

Nissen ED, Kent DR, Nissen SE: Etiologic factors in the pathogenesis of liver tumors associated with oral contraceptives. Am J Obstet Gynecol. 1977, 127 (1): 61-66.CrossRefPubMed

Rooks JB, Ory HW, Ishak KG, Strauss LT, Greenspan JR, Tyler CW: The association between oral contraception and hepatocellular adenoma–a preliminary report. Int J Gynaecol Obstet. 1977, 15 (2): 143-144.PubMed

Stoot JH, Coelen RJ, De Jong MC, Dejong CH: Malignant transformation of hepatocellular adenomas into hepatocellular carcinomas: a systematic review including more than 1600 adenoma cases. HPB (Oxford). 2010, 12 (8): 509-522. 10.1111/j.1477-2574.2010.00222.x.CrossRef

10.

Aseni P, Sansalone CV, Sammartino C, Benedetto FD, Carrafiello G, Giacomoni A, Osio C, Vertemati M, Forti D: Rapid disappearance of hepatic adenoma after contraceptive withdrawal. J Clin Gastroenterol. 2001, 33 (3): 234-236. 10.1097/00004836-200109000-00015.CrossRefPubMed

11.

Buhler H, Pirovino M, Akobiantz A, Altorfer J, Weitzel M, Maranta E, Schmid M: Regression of liver cell adenoma. A follow-up study of three consecutive patients after discontinuation of oral contraceptive use. Gastroenterology. 1982, 82 (4): 775-782.PubMed

12.

Edmondson HA, Reynolds TB, Henderson B, Benton B: Regression of liver cell adenomas associated with oral contraceptives. Ann Intern Med. 1977, 86 (2): 180-182.CrossRefPubMed

13.

Steinbrecher UP, Lisbona R, Huang SN, Mishkin S: Complete regression of hepatocellular adenoma after withdrawal of oral contraceptives. Dig Dis Sci. 1981, 26 (11): 1045-1050. 10.1007/BF01314771.CrossRefPubMed

14.

Terkivatan T, de Wilt JH, de Man RA, van Rijn RR, Tilanus HW, IJ JN: Treatment of ruptured hepatocellular adenoma. Br J Surg. 2001, 88 (2): 207-209. 10.1046/j.1365-2168.2001.01648.x.CrossRefPubMed

15.

Terkivatan T, de Wilt JH, de Man RA, van Rijn RR, Zondervan PE, Tilanus HW, IJ JN: Indications and long-term outcome of treatment for benign hepatic tumors: a critical appraisal. Arch Surg. 2001, 136 (9): 1033-1038. 10.1001/archsurg.136.9.1033.CrossRefPubMed

16.

Ault GT, Wren SM, Ralls PW, Reynolds TB, Stain SC: Selective management of hepatic adenomas. Am Surg. 1996, 62 (10): 825-829.PubMed

17.

Dokmak S, Paradis V, Vilgrain V, Sauvanet A, Farges O, Valla D, Bedossa P, Belghiti J: A single-center surgical experience of 122 patients with single and multiple hepatocellular adenomas. Gastroenterology. 2009, 137 (5): 1698-1705. 10.1053/j.gastro.2009.07.061.CrossRefPubMed

18.

van Aalten SM, Terkivatan T, de Man RA, van der Windt DJ, Kok NF, Dwarkasing R, Ijzermans JN: Diagnosis and treatment of hepatocellular adenoma in the Netherlands: similarities and differences. Dig Surg. 2010, 27 (1): 61-67. 10.1159/000268587.CrossRefPubMed

19.

van der Windt DJ, Kok NF, Hussain SM, Zondervan PE, Alwayn IP, de Man RA, IJ JN: Case-orientated approach to the management of hepatocellular adenoma. Br J Surg. 2006, 93 (12): 1495-1502. 10.1002/bjs.5511.CrossRefPubMed

20.

Cobey FC, Salem RR: A review of liver masses in pregnancy and a proposed algorithm for their diagnosis and management. Am J Surg. 2004, 187 (2): 181-191. 10.1016/j.amjsurg.2003.11.016.CrossRefPubMed

21.

Noels JE, van Aalten SM, van der Windt DJ, Kok NFM, de Man RA, Terkivatan T, IJzermans JNM: Management of Hepatocellular Adenoma During Pregnancy. J Hepatol. 2011, 54 (3): 553-8. 10.1016/j.jhep.2010.07.022.CrossRefPubMed

22.

Evers AC, Brouwers HA, Hukkelhoven CW, Nikkels PG, Boon J, van Egmond-Linden A, Hillegersberg J, Snuif YS, Sterken-Hooisma S, Bruinse HW, et al: Perinatal mortality and severe morbidity in low and high risk term pregnancies in the Netherlands: prospective cohort study. BMJ. 2010, 341: c5639-10.1136/bmj.c5639.CrossRefPubMed

23.

Amelink-Verburg MP, Buitendijk SE: Pregnancy and labour in the Dutch maternity care system: what is normal? The role division between midwives and obstetricians. J Midwifery Womens Health. 2010, 55 (3): 216-225. 10.1016/j.jmwh.2010.01.001.CrossRefPubMed

24.

Bioulac-Sage P, Balabaud C, Zucman-Rossi J: Subtype classification of hepatocellular adenoma. Dig Surg. 2010, 27 (1): 39-45. 10.1159/000268406.CrossRefPubMed

25.

Norman GR, Sloan JA, Wyrwich KW: Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care. 2003, 41 (5): 582-592.PubMed

26.

Yumi H: Guidelines for diagnosis, treatment, and use of laparoscopy for surgical problems during pregnancy: this statement was reviewed and approved by the Board of Governors of the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES), September 2007. It was prepared by the SAGES Guidelines Committee. Surg Endosc. 2008, 22 (4): 849-861.CrossRefPubMed

27.

Hua X, Zhu LP, Li R, Zhong H, Xue YF, Chen ZH: Effects of diagnostic contrast-enhanced ultrasound on permeability of placental barrier: a primary study. Placenta. 2009, 30 (9): 780-784. 10.1016/j.placenta.2009.06.009.CrossRefPubMed

28.

Kort B, Katz VL, Watson WJ: The effect of nonobstetric operation during pregnancy. Surg Gynecol Obstet. 1993, 177 (4): 371-376.PubMed

29.

Visser BC, Glasgow RE, Mulvihill KK, Mulvihill SJ: Safety and timing of nonobstetric abdominal surgery in pregnancy. Dig Surg. 2001, 18 (5): 409-417. 10.1159/000050183.CrossRefPubMed

30.

Parangi S, Levine D, Henry A, Isakovich N, Pories S: Surgical gastrointestinal disorders during pregnancy. Am J Surg. 2007, 193 (2): 223-232. 10.1016/j.amjsurg.2006.04.021.CrossRefPubMed

31.

Wilson CH, Manas DM, French JJ: Laparoscopic Liver Resection for Hepatic Adenoma in Pregnancy. J Clin Gastroenterol. 2011, 45 (9): 828-33. 10.1097/MCG.0b013e3181f97747.CrossRefPubMed

32.

Fujita S, Kushihata F, Herrmann GE, Mergo PJ, Liu C, Nelson D, Fujikawa T, Hemming AW: Combined hepatic resection and radiofrequency ablation for multiple hepatic adenomas. J Gastroenterol Hepatol. 2006, 21 (8): 1351-1354. 10.1111/j.1440-1746.2006.03184.x.CrossRefPubMed

The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-230X/12/82/prepub

Title: Pregnancy and liver adenoma management: PALM-study
Authors: Susanna M van Aalten
Mirelle E E Bröker
J J V Busschbach
Harry J de Koning
Robert A de Man
Eric A P Steegers
Ewout W Steyerberg
Turkan Terkivatan
Jan N M IJzermans
Publication date: 01-12-2012
Publisher: BioMed Central
Published in: BMC Gastroenterology / Issue 1/2012
Electronic ISSN: 1471-230X
DOI: https://doi.org/10.1186/1471-230X-12-82

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Pregnancy and liver adenoma management: PALM-study

Abstract

Background

Methods/design

Discussion

Trial registration

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Background

Methods/design

Discussion

Trial registration

Please log in to get access to this content

Other articles of this Issue 1/2012

Efficacy of omeprazole, famotidine, mosapride and teprenone in patients with upper gastrointestinal symptoms: an omeprazole-controlled randomized study (J-FOCUS)

Applicability of a short/rapid 13C-urea breath test for Helicobacter pylori: retrospective multicenter chart review study

Genetic deletion of dectin-1 does not affect the course of murine experimental colitis

Analysis of the causes and clinical characteristics of jejunoileal hemorrhage in China: a multicenter 10 year retrospective survey

Back-to-Back Comparison of Auto-Fluorescence Imaging (AFI) Versus High Resolution White Light Colonoscopy for Adenoma Detection

Low incidence of positive smooth muscle antibody and high incidence of isolated IgM elevation in Chinese patients with autoimmune hepatitis and primary biliary cirrhosis overlap syndrome: a retrospective study

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page